# To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

> **NCT06361277** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Reference Drug or Test Drug

## Key facts

- **NCT ID:** NCT06361277
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-03
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-27
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361277, "To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06361277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*